Access to Biomarker Testing Press Releases
**MEDIA ADVISORY—SPOKESPEOPLE AVAILABLE** Cancer Action Day Brings Advocates to Capitol in Support of “Jill’s Law” Ensuring Access to Biomarker Testing
JACKSON, Miss. – Dozens of cancer patients, survivors, caregivers and advocates will come from across Mississippi to the State Capitol on Wednesday, February 4 for the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day.
Mississippi House Passes 'Jill's Law' for Biomarker Testing Coverage
JACKSON, Miss. – The Mississippi House passed House Bill 565 Wednesday, paving the way for increased access to biomarker testing for patients across the Magnolia State.
Hawai’i Cancer Community Urges State Lawmakers to Defend Medicaid and Expand Colon Cancer Screening Access
With the 2026 legislative session now underway in Hawai’i, the American Cancer Society Cancer Action Network (ACS CAN) is leading efforts to work with lawmakers on several initiatives which include defending Medicaid and expanding access to screenings for colorectal cancer for the state’s most vu
Ahead of State of the State, Cancer-Fighting Advocates Call on Gov. Mills to Prioritize Public Health in 2026
Ahead of Mills' State of the State address, ACS CAN Calls Attention to Medicaid, Biomarker Testing and Medical Debt
New Study Underscores Importance of Pharmacogenomic Testing to Patients and Finds Many Aren’t Aware of the Benefits
A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
Massachusetts cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine and patient navigation for all communities.
Senate & House Vote Unanimously to Increase Access to Biomarker Testing
Expanding access to this form of precision medicine will help more people in Connecticut get the right treatment at the right time.
Connecticut House Votes to Improve Access to Biomarker Testing
Leading public health group urges Senate and Gov. Lamont to follow suit in ensuring biomarker testing can benefit more Connecticut patients
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
Leading public health group urges Senate and Gov. Lamont to follow suit in ensuring biomarker testing can benefit more Connecticut patients